Wellmedr vs Start Willow: Pricing, Shipping, Compounded Meds Compared

How pricing and long-term cost compare

Price is a primary difference in this Wellmedr vs Start Willow comparison. Wellmedr lists GLP-1 plans starting at $89 per month and mentions semaglutide monthly plans starting at $49 a month on some offers. Wellmedr also markets lifetime locked-in pricing and a New Customer Offer of $150 off for life, subject to enrollment terms. Start Willow lists semaglutide from $249 per month with the first month priced at $249 and ongoing $299 per month in captured FAQ content. Start Willow notes there are no membership fees or insurance requirements.

View Start Willow semaglutide from $249/mo

Shipping speed, delivery guarantees, and review timing

Both providers highlight delivery timing but with different promises. Wellmedr advertises same-day review plus free overnight shipping and on-time refills guaranteed for some plans. Start Willow guarantees delivery in 3 days or less from its licensed pharmacy network and states in some captures that prescriptions can be dispensed same day with free 2-day shipping when in stock. These are direct claims captured from each provider.

Compounding, regulatory notes, and medication options

Both Wellmedr and Start Willow offer compounded GLP-1 medications according to the captured evidence. Wellmedr explicitly notes it offers compounded GLP-1 medications exclusively from licensed U.S. pharmacies and includes the regulatory notice that compounded medications are regulated by state Boards of Pharmacy but are not evaluated by the FDA for safety or efficacy. Start Willow likewise states that compounded semaglutide is not approved by the FDA and that such medications are prepared by state-licensed compounding pharmacies under state board of pharmacy oversight and USP compounding standards. Start Willow emphasizes semaglutide as a once-weekly compounded injection prescribed as part of a personalized plan and notes medications comparable to Ozempic and tirzepatide. Wellmedr lists tirzepatide and semaglutide among plan options and includes branded price references captured on landing pages.

Care model differences and patient suitability

Wellmedr presents features like lifetime locked-in pricing, no dose-based price increases, same-day review, and claims a money back guarantee as captured, with the qualification that new offers and terms apply. Start Willow highlights a direct-pay model with no insurance and no membership fees, marketed as a fit for patients who have experienced insurance pre-authorization denials, and emphasizes personalized clinician collaboration for compounded semaglutide formulations.

Five-point comparison table

Criterion	Wellmedr	Start Willow
Starting price	Semaglutide from $49 to GLP-1 plans starting at $89/mo	From $249 per month ($249 first month, $299 ongoing noted)
Pricing features	Lifetime locked-in pricing; no dose-based price increases; New Customer Offer captured	No membership fees; direct-pay model; first month $249 then $299 ongoing
Shipping and review	Same-day review plus free overnight shipping; on-time refills guaranteed	Delivery in 3 days or less; same day prescriptions and free 2-day shipping when in stock
Medication type	Offers compounded GLP-1 medications; lists semaglutide and tirzepatide	Compounded semaglutide; medications comparable to Ozempic and tirzepatide
Regulatory note	Compounded meds not reviewed by FDA; regulated by state Boards of Pharmacy	Compounded meds not approved by FDA; prepared under state board oversight and USP standards

Safety and outcome language to note

Both providers include captured safety and outcome qualifiers. Wellmedr’s captured language includes the required safety notice about risks such as thyroid C-cell tumors and that compounded medications are not evaluated by the FDA. Wellmedr also states that clinical research on GLP-1 medications often shows double-digit weight loss in trials but clarifies that information reflects published research and not outcomes specific to Wellmedr. Start Willow’s captured material likewise notes common side effects such as nausea and that stopping semaglutide may lead to weight changes, and it recommends tapering with a physician. All plans require clinician review and approval per the captured evidence.

Practical guidance and final comparison

Wellmedr vs Start Willow differs most on price, delivery promise timing, and emphasis on direct-pay personalization versus lifetime pricing offers. Wellmedr is shown in captured evidence to focus on lower starting prices, lifetime locked-in pricing, and same-day review plus overnight shipping. Start Willow is shown to focus on a no-insurance, no-membership direct-pay model with a 3-day delivery guarantee and personalized compounded semaglutide plans, with ongoing pricing captured at $299 per month.

Check WellMedr eligibility and plans

See Start Willow semaglutide options

Start WellMedr enrollment and lock pricing

Choose Wellmedr if…

Choose Wellmedr if you prioritize lower starting prices and the captured offers such as lifetime locked-in pricing, no dose-based price increases, and same-day review with overnight shipping as presented in the evidence.

Choose Start Willow if…

Choose Start Willow if you need a direct-pay option that requires no insurance or membership, value a personalized compounded semaglutide formulation prescribed by a clinician, or prioritize the captured 3-day delivery guarantee and faster dispensing language in the evidence.

Both providers include captured regulatory disclaimers that compounded medications are not FDA-approved and require clinician review and approval. Wellmedr vs Start Willow comparison reflects only the captured statements and qualifiers provided in source material.